title: Characteristics and occurrence of speech impairment in Huntington's disease: possible influence of antipsychotic medication.
abstract: Although motor speech impairment is a common manifestation of Huntington's disease (HD), its description remains limited. The aim of the current study was therefore to estimate the occurrence and characteristics of speech disorder in HD and to explore the influence of antipsychotic medication on speech performance. Speech samples, including reading passage and monologue, were acquired from 40 individuals diagnosed with HD and 40 age- and sex-matched healthy controls. Objective acoustic analyses were used to evaluate key aspects of speech including vowel articulation, intensity, pitch and timing. A predictive model was constructed to detect the occurrence and most prominent patterns of speech dysfunction in HD. We revealed that 93% of HD patients manifest some degree of speech impairment. Decreased number of pauses, slower articulation rate, imprecise vowel articulation and excess intensity variations were found to be the most salient patterns of speech dysfunction in HD. We further demonstrated that antipsychotic medication may induce excessive loudness and pitch variations perceptually resembling excess patterns of word stress, and may also accentuate general problems with speech timing. Additionally, antipsychotics induced a slight improvement of vowel articulation. Specific speech alterations observed in HD patients indicate that speech production may reflect the pathophysiology of the disease as well as treatment effects, and may therefore be considered a valuable marker of functional disability in HD.
authors.affiliation: Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Technická 2, 160 00, Prague 6, Czech Republic, rusz.mz@gmail.com.
authors.forename: Jan
authors.initials: J
authors.lastname: Rusz
authors.forename: Jiří
authors.initials: J
authors.lastname: Klempíř
authors.forename: Tereza
authors.initials: T
authors.lastname: Tykalová
authors.forename: Eva
authors.initials: E
authors.lastname: Baborová
authors.forename: Roman
authors.initials: R
authors.lastname: Čmejla
authors.forename: Evžen
authors.initials: E
authors.lastname: Růžička
authors.forename: Jan
authors.initials: J
authors.lastname: Roth
mesh_terms: D000161:Acoustic Stimulation; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000009:adverse effects*; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013064:Speech Disorders / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology; D018709:Statistics, Nonparametric; D064232:Visual Analog Scale; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents